Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Prepaid Assets (2021 - 2025)

Lyra Therapeutics has reported Prepaid Assets over the past 5 years, most recently at $379000.0 for Q4 2025.

  • Quarterly results put Prepaid Assets at $379000.0 for Q4 2025, down 84.52% from a year ago — trailing twelve months through Dec 2025 was $379000.0 (down 84.52% YoY), and the annual figure for FY2025 was $379000.0, down 84.52%.
  • Prepaid Assets for Q4 2025 was $379000.0 at Lyra Therapeutics, down from $964000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for LYRA hit a ceiling of $2.9 million in Q4 2022 and a floor of $379000.0 in Q4 2025.
  • Median Prepaid Assets over the past 5 years was $2.1 million (2023), compared with a mean of $1.9 million.
  • Biggest five-year swings in Prepaid Assets: soared 44.46% in 2022 and later plummeted 84.52% in 2025.
  • Lyra Therapeutics' Prepaid Assets stood at $2.2 million in 2021, then soared by 35.19% to $2.9 million in 2022, then decreased by 29.54% to $2.1 million in 2023, then grew by 18.38% to $2.4 million in 2024, then plummeted by 84.52% to $379000.0 in 2025.
  • The last three reported values for Prepaid Assets were $379000.0 (Q4 2025), $964000.0 (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.